文献速递妇科

美国国家综合癌症网络(NCCN)中心子宫内膜癌微创子宫切除术的实施率

Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.
PubMed 文献 · Gynecol Oncol · 2018-01-12

本研究为回顾性队列研究,评估2013至2014年四家NCCN中心收治的1621例子宫内膜癌患者手术方式,86.5%接受微创手术(机器人辅助72.5%、腹腔镜20.9%、阴道6.6%),微创手术围手术期并发症低于开腹手术,在高容量中心微创率>80%的基准可行。

要点

  • 在四家NCCN中心,1621例子宫内膜癌患者中86.5%接受了微创手术。
  • Ⅰ/Ⅱ期患者中,微创手术并发症发生率为5.1%,开腹手术为21.7%(p<0.01)。
  • 开腹手术与任何并发症、胃肠道、伤口、呼吸系统、静脉血栓栓塞及30天再入院风险增加相关。

核心结论

  • 在NCCN指定中心,子宫内膜癌微创子宫切除术率高于已发表的国家平均水平,围手术期并发症低,既往报道的年龄、种族和BMI差异未观察到,在高容量中心实施微创子宫切除术>80%的基准是可行的。

研究设计与样本

  • 回顾性队列研究,纳入2013至2014年在四家NCCN中心接受手术治疗的子宫内膜癌女性,共1621例。

主要发现

  • 1621例患者中86.5%接受微创手术,其中机器人辅助72.5%、腹腔镜20.9%、阴道6.6%。
  • 多因素分析中,未接受微创手术的相关因素包括子宫大小>12cm(OR 0.17,95%CI 0.03-0.9)、III期(OR 0.16,95%CI 0.05-0.49)和IV期疾病(OR 0.07,95%CI 0.02-0.22)。
  • 对于I/II期疾病,微创手术组并发症发生率为5.1%,开腹手术组为21.7%(p<0.01)。
  • 与微创手术相比,开腹手术与任何并发症(OR 6.0,95%CI 3.3-10.8)、胃肠道并发症(OR 7.2,95%CI 2.6-19.5)、伤口并发症(OR 3.7,95%CI 1.5-9.2)、呼吸系统并发症(OR 37.5,95%CI 3.9-358.0)、静脉血栓栓塞(OR 10.5,95%CI 1.3-82.8)及30天再入院(OR 2.6,95%CI 1.4-4.9)风险增加相关。

临床怎么用

  • 作者认为,在高容量中心实施子宫内膜癌微创子宫切除术>80%的基准是可行的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Minimally invasive surgery (MIS) is a quality measure for endometrial cancer (EC) established by the Society of Gynecologic Oncology and the American College of Surgeons. Our study objective was to assess the proportion of EC cases performed by MIS at National Comprehensive Cancer Network (NCCN) centers and evaluate perioperative outcomes. METHODS: A retrospective cohort study of women who underwent surgical treatment for EC from 2013 to 2014 was conducted at four NCCN centers. Multivariable mixed logistic regression models analyzed factors associated with failure to perform MIS and perioperative complications. RESULTS: In total 1621 patients were evaluated; 86.5% underwent MIS (robotic-assisted 72.5%, laparoscopic 20.9%, vaginal 6.6%). On multivariable analysis, factors associated with failure to undergo MIS were uterine size >12cm (Odds Ratio [OR]: 0.17, 95% CI 0.03-0.9), stage III (OR: 0.16, 95% CI 0.05-0.49) and IV disease (OR: 0.07, 95% CI 0.02-0.22). For stage I/II disease, complications occurred in 5.1% of MIS and 21.7% of laparotomy cases (p<0.01). Laparotomy was associated with increases in any complication (OR: 6.0, 95% CI 3.3-10.8), gastrointestinal (OR: 7.2, 95% CI 2.6-19.5), wound (OR: 3.7, 95% CI 1.5-9.2), respiratory (OR 37.5, 95% CI 3.9-358.0), VTE (OR 10.5, 95% CI 1.3-82.8) and 30-day readmission (OR: 2.6, 95% CI 1.4-4.9) compared to MIS. CONCLUSIONS: At NCCN-designated centers, the MIS hysterectomy rate in EC is higher than the published national average, with low perioperative complications. Previously identified disparities of age, race, and BMI were not observed. A proposed MIS hysterectomy benchmark of >80% in EC care is feasible when performed at high volume centers.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bergstrom J, Aloisi A, Armbruster S, et al. Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers. Gynecol Oncol. 2018. PMID: 29338923. doi:10.1016/j.ygyno.2018.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。